Skip to main content
All tenders

Discount Agreement for Clobazam (TAB) by DAK-Gesundheit

Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo TAB), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)

Status
Active
Submission Deadline
913 days remaining
Contracting authority
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-265426-2026

DAK-Gesundheit is seeking partners for a non-exclusive discount agreement for Clobazam (TAB) from 01.06.2026 to 31.05.2028, with an extension option. This allows all pharmaceutical companies to join under attractive conditions.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 265426-2026HTML
  • TED PDF — 265426-2026PDF
  • TED XML — 265426-2026XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Additional details

EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024

Similar tenders

Explore CPV 33

Current tenders in CPV division 33 are listed on the Akademie page for this category.

Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context

Prefer a private session?